We quantified how much of ganciclovir’s effect on clinical outcomes could be attributed to its effect on VL kinetics. This quantity is called the proportion of treatment effect captured by the surrogate (PCS) (23). A PCS higher than 63% is considered “moderate;” PCS higher than 85% is “substantial”; and PCS higher than 93% is “almost perfect” (23). Details regarding the PCS method and our implementation are provided in the Supplemental Methods.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.